TSC22D3 and systemic lupus erythematosus: Reduced GILZ expression levels were observed in the B lymphocytes of patients with Systemic lupus erythematosus (SLE), a multisystem autoimmune disease, and decreased GILZ expression in GC-treated SLE patients was associated with an increased disease activity [83].